DERRICK MUSE: Open Payments
NPI 1720157555 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,386 in 51 payments from 20 companies in 2025. Trend: 2023 $2,222 · 2024 $1,922 · 2025 $2,386
Travel & lodging: $1,400Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $1,694 |
| ABBVIE INC. | 10 | $198 |
| Medtronic, Inc. | 3 | $52 |
| Amgen Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| PFIZER INC. | 3 | $48 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $32 |
| SI-BONE, INC. | 1 | $21 |
Products named: UBRELVY, INCEPTIV, MOUNJARO, NURTEC ODT, VRAYLAR, JOURNAVX, QULIPTA, OTEZLA.
Industry payments across UT — which companies pay providers there.
